Althea Group Holdings Limited (ASX:AGH)

Market Cap	18.18M
Revenue (ttm)	15.49M
Net Income (ttm)	-8.35M
Shares Out	845.47M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	125,077
Average Volume	746,858
Open	0.0210
Previous Close	0.0220
Day's Range	0.0210 - 0.0220
52-Week Range	0.0180 - 0.0540
Beta	1.34
RSI	43.02
Earnings Date	Aug 28, 2025

About Althea Group Holdings

Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private med...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AGH

Financial Performance

In 2025, Althea Group Holdings's revenue was 15.49 million, a decrease of -48.97% compared to the previous year's 30.37 million. Losses were -8.35 million, -73.96% less than in 2024.